Skip to Main Content

Study of Safety and of the Mechanism of BLZ945 in ALS Patients


Diseases of the Nervous System

Phase II

What is the purpose of this trial?

This is an open label study to evaluate safety, tolerability and brain microglia response in participants with ALS following multiple doses of BLZ945.

  • Trial with
    Novartis Pharmaceuticals
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC